(Q36623819)
Statements
ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model (English)
I J Stratford
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference